CompletedPhase 1NCT00317473

Phase 1 Trial of a Malaria Vaccine in Young Kenyan Children

Studying Malaria

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
U.S. Army Medical Research and Development Command
Principal Investigator
Mark R. Withers, M.D., MPH
USAMRU-K
Intervention
FMP1/AS02A Malaria vaccine(biological)
Enrollment
135 enrolled
Eligibility
All sexes
Timeline
20032005

Study locations (1)

Collaborators

Kenya Medical Research Institute · Walter Reed Army Institute of Research (WRAIR) · The PATH Malaria Vaccine Initiative (MVI) · United States Agency for International Development (USAID) · GlaxoSmithKline

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00317473 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria

← Back to all trials